A Root-Based Combination Supplement Containing Pueraria lobata and Rehmannia glutinosa and Exercise Preserve Bone Mass in Ovariectomized Rats Fed a High-Fat Diet

Calcified Tissue International

Volumn 97, Issue 6, 2015, Pages 624-633

  Ok, Hyang Mok ^a   Gebreamanuel, Meron Regu ^a   Oh, Sang A ^a   Jeon, Hyejin ^a   Lee, Won Jun ^a   Kwon, Oran ^a  

^a Ewha Womans University   (South Korea)

Author keywords

Exercise; Osteoporosis; Ovariectomy; Postmenopausal; Pueraria lobata; Rehmanniaglutinosa

Indexed keywords

ALKALINE PHOSPHATASE; ALKALINE PHOSPHATASE BONE ISOENZYME; COLLAGEN TYPE 1; ESTRADIOL; OSTEOCALCIN; OSTEOCLAST DIFFERENTIATION FACTOR; PUERARIA EXTRACT; PUERARIA LOBATA EXTRACT; REHMANNIA GLUTINOSA EXTRACT; UNCLASSIFIED DRUG; PLANT EXTRACT;

AEROBIC EXERCISE; ALKALINE PHOSPHATASE BLOOD LEVEL; ANIMAL EXPERIMENT; ARTICLE; BONE MASS; BONE TURNOVER; COMPUTED TOMOGRAPHY SCANNER; CONTROLLED STUDY; DOWN REGULATION; ENZYME LINKED IMMUNOSORBENT ASSAY; ESTROGEN DEFICIENCY; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HORMONE SUBSTITUTION; LIPID DIET; LOW FAT DIET; MARKER GENE; MICRO-COMPUTED TOMOGRAPHY; NONHUMAN; OSTEOLYSIS; OSTEOPOROSIS; OVARIECTOMY; POSTMENOPAUSE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PUERARIA LOBATA; QUANTITATIVE ANALYSIS; RAT; REAL TIME POLYMERASE CHAIN REACTION; REHMANNIA GLUTINOSA; SUPPLEMENTATION; ANIMAL; BONE DENSITY; BONE REMODELING; DIETARY SUPPLEMENT; DISEASE MODEL; DRUG EFFECTS; HUMAN; OSTEOPOROSIS, POSTMENOPAUSAL; PHYTOTHERAPY; PLANT ROOT; PROCEDURES; PUERARIA; REHMANNIA; SPRAGUE DAWLEY RAT;

ANIMALS; BONE DENSITY; BONE REMODELING; DIET, HIGH-FAT; DIETARY SUPPLEMENTS; DISEASE MODELS, ANIMAL; FEMALE; HUMANS; OSTEOPOROSIS, POSTMENOPAUSAL; OVARIECTOMY; PHYTOTHERAPY; PLANT EXTRACTS; PLANT ROOTS; PUERARIA; RATS; RATS, SPRAGUE-DAWLEY; REAL-TIME POLYMERASE CHAIN REACTION; REHMANNIA; X-RAY MICROTOMOGRAPHY;

EID: 84946473457     PISSN: 0171967X     EISSN: 14320827     Source Type: Journal    
DOI: 10.1007/s00223-015-0057-7     Document Type: Article

References (37)

1. Deal C (2009) Potential new drug targets for osteoporosis. Nat Clin Pract Rheumatol 5:20–27
2. Ray NF, Chan JK, Thamer M, Melton LJ 3rd (1997) Medical expenditures for the treatment of osteoporotic fractures in the United States in 1995: report from the National Osteoporosis Foundation. J Bone Miner Res 12:24–35
3. Geusens P, Dinant G (2007) Integrating a gender dimension into osteoporosis and fracture risk research. Gend Med 4(Suppl B):S147–S161
4. Kanis JA, Johnell O, Oden A, Jonsson B, De Laet C, Dawson A (2000) Risk of hip fracture according to the World Health Organization criteria for osteopenia and osteoporosis. Bone 27:585–590
5. Zhao LJ, Jiang H, Papasian CJ, Maulik D, Drees B, Hamilton J, Deng HW (2008) Correlation of obesity and osteoporosis: effect of fat mass on the determination of osteoporosis. J Bone Miner Res 23:17–29
6. Lacey JV Jr, Mink PJ, Lubin JH, Sherman ME, Troisi R, Hartge P, Schatzkin A, Schairer C (2002) Menopausal hormone replacement therapy and risk of ovarian cancer. JAMA 288:334–341
7. Beral V, Million Women Study C (2003) Breast cancer and hormone-replacement therapy in the Million Women Study. Lancet 362:419–427
8. Fitzpatrick LA (1999) Selective estrogen receptor modulators and phytoestrogens: new therapies for the postmenopausal women. Mayo Clin Proc 74:601–607
9. Oh KO, Kim SW, Kim JY, Ko SY, Kim HM, Baek JH, Ryoo HM, Kim JK (2003) Effect of Rehmannia glutinosa Libosch extracts on bone metabolism. Clin Chim Acta 334:185–195
10. Shiguemoto GE, Rossi EA, Baldissera V, Gouveia CH, de Valdez Vargas GM, de Andrade Perez SE (2007) Isoflavone-supplemented soy yoghurt associated with resistive physical exercise increase bone mineral density of ovariectomized rats. Maturitas 57:261–270
11. Wu J, Wang X, Chiba H, Higuchi M, Nakatani T, Ezaki O, Cui H, Yamada K, Ishimi Y (2004) Combined intervention of soy isoflavone and moderate exercise prevents body fat elevation and bone loss in ovariectomized mice. Metab Clin Exp 53:942–948
12. Evans EM, Racette SB, Van Pelt RE, Peterson LR, Villareal DT (2007) Effects of soy protein isolate and moderate exercise on bone turnover and bone mineral density in postmenopausal women. Menopause 14:481–488
13. Nakajima D, Kim CS, Oh TW, Yang CY, Naka T, Igawa S, Ohta F (2001) Suppressive effects of genistein dosage and resistance exercise on bone loss in ovariectomized rats. J Physiol Anthropol Appl Human Sci 20:285–291
14. Trivedi R, Kumar A, Gupta V, Kumar S, Nagar GK, Romero JR, Dwivedi AK, Chattopadhyay N (2009) Effects of Egb 761 on bone mineral density, bone microstructure, and osteoblast function: possible roles of quercetin and kaempferol. Mol Cell Endocrinol 302:86–91
15. Delmas PD, Schlemmer A, Gineyts E, Riis B, Christiansen C (1991) Urinary excretion of pyridinoline crosslinks correlates with bone turnover measured on iliac crest biopsy in patients with vertebral osteoporosis. J Bone Miner Res 6:639–644
16. Alves-Rodrigues A, Shao A (2004) The science behind lutein. Toxicol Lett 150:57–83
17. Simonet WS, Lacey DL, Dunstan CR, Kelley M, Chang MS, Luthy R, Nguyen HQ, Wooden S, Bennett L, Boone T, Shimamoto G, DeRose M, Elliott R, Colombero A, Tan HL, Trail G, Sullivan J, Davy E, Bucay N, Renshaw-Gegg L, Hughes TM, Hill D, Pattison W, Campbell P, Sander S, Van G, Tarpley J, Derby P, Lee R, Boyle WJ (1997) Osteoprotegerin: a novel secreted protein involved in the regulation of bone density. Cell 89:309–319
18. Kalu DN (1991) The ovariectomized rat model of postmenopausal bone loss. Bone Miner 15:175–191
19. Brzezinski A, Debi A (1999) Phytoestrogens: the “natural” selective estrogen receptor modulators? Eur J Obstet Gynecol Reprod Biol 85:47–51
20. Sharan K, Siddiqui JA, Swarnkar G, Maurya R, Chattopadhyay N (2009) Role of phytochemicals in the prevention of menopausal bone loss: evidence from in vitro and in vivo, human interventional and pharma-cokinetic studies. Curr Med Chem 16:1138–1157
21. Chiechi LM, Lobascio A, Grillo A, Valerio T (1999) Phytoestrogen-containing food and prevention of postmenopausal osteoporosis and cardiovascular diseases. Miner Ginecol 51:343–348
22. Cherdshewasart W, Subtang S, Dahlan W (2007) Major isoflavonoid contents of the phytoestrogen rich-herb Pueraria mirifica in comparison with Pueraria lobata. J Pharm Biomed Anal 43:428–434
23. Michihara S, Tanaka T, Uzawa Y, Moriyama T, Kawamura Y (2012) Puerarin exerted anti-osteoporotic action independent of estrogen receptor-mediated pathway. J Nutr Sci Vitaminol 58:202–209
24. Mody N, Parhami F, Sarafian TA, Demer LL (2001) Oxidative stress modulates osteoblastic differentiation of vascular and bone cells. Free Radic Biol Med 31:509–519
25. Seibel MJ (2005) Biochemical markers of bone turnover: part I: biochemistry and variability. Clin Biochem 26:97–122
26. Devareddy L, Khalil DA, Smith BJ, Lucas EA, Soung do Y, Marlow DD, Arjmandi BH (2006) Soy moderately improves microstructural properties without affecting bone mass in an ovariectomized rat model of osteoporosis. Bone 38:686–693
27. Laib A, Beuf O, Issever A, Newitt DC, Majumdar S (2001) Direct measures of trabecular bone architecture from MR images. Adv Exp Med Biol 496:37–46
28. Ding M, Odgaard A, Hvid I (2003) Changes in the three-dimensional microstructure of human tibial cancellous bone in early osteoarthritis. J Bone Joint Surg 85:906–912
29. Hahn M, Vogel M, Pompesius-Kempa M, Delling G (1992) Trabecular bone pattern factor—a new parameter for simple quantification of bone microarchitecture. Bone 13:327–330
30. Chaffai S, Peyrin F, Nuzzo S, Porcher R, Berger G, Laugier P (2002) Ultrasonic characterization of human cancellous bone using transmission and backscatter measurements: relationships to density and microstructure. Bone 30:229–237
31. Boyce BF, Xing LP (2008) Functions of RANKL/RANK/OPG in bone modeling and remodeling. Arch Biochem Biophys 473:139–146
32. Kobayashi Y, Udagawa N, Takahashi N (2009) Action of RANKL and OPG for Osteoclastogenesis. Crit Rev Eukar Gene 19:61–72
33. Teitelbaum SL (2000) Bone resorption by osteoclasts. Science 289:1504–1508
34. Udomsuk L, Chatuphonprasert W, Monthakantirat O, Churikhit Y, Jarukamjorn K (2012) Impact of Pueraria candollei var. mirifica and its potent phytoestrogen miroestrol on expression of bone-specific genes in ovariectomized mice. Fitoterapia 83:1687–1692
35. Delmas PD, Eastell R, Garnero P, Seibel MJ, Stepan J, Committee of Scientific Advisors of the International Osteoporosis Foundation (2000) The use of biochemical markers of bone turnover in osteoporosis. Osteoporos Int 11(Suppl 6):S2–S17
36. Khedgikar V, Gautam J, Kushwaha P, Kumar A, Nagar GK, Dixit P, Chillara R, Voruganti S, Singh SP, Uddin W, Jain GK, Singh D, Maurya R, Chattopadhyay N, Trivedi R (2012) A standardized phytopreparation from an Indian medicinal plant (Dalbergia sissoo) has antiresorptive and bone-forming effects on a postmenopausal osteoporosis model of rat. Menopause 19:1336–1346
37. Liu HY, Liu MC, Wang MF, Chen WH, Tsai CY, Wu KH, Lin CT, Shieh YH, Zeng R, Deng WP (2013) Potential osteoporosis recovery by deep sea water through bone regeneration in SAMP8 mice. Evid Based Complement Altern Med 2013:161976